Exact Mass: 602.1636174
Exact Mass Matches: 602.1636174
Found 89 metabolites which its exact mass value is equals to given mass value 602.1636174
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amaroswerin
Amaroswerin is a member of biphenyls. Amaroswerin is a natural product found in Swertia japonica, Gentianella nitida, and other organisms with data available. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1]. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1].
10-Formyl-THF-L-glutamate
Eriodictyol 7-(6-galloylglucoside)
Eriodictyol 7-(6-galloylglucoside) is found in fruits. Eriodictyol 7-(6-galloylglucoside) is a constituent of the leaves and branches of Phyllanthus emblica (emblic). Constituent of the leaves and branches of Phyllanthus emblica (emblic). Eriodictyol 7-(6-galloylglucoside) is found in fruits.
Tipranavir
Tipranavir is only found in individuals that have used or taken this drug. It is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. It is administered with ritonavir in combination therapy to treat HIV infections.Tipranavir inhibits the processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions. Two mechanisms are suggested in regards to the potency of tipranavir: 1. Tipravanir may bind to the active site of the protease enzyme with fewer hydrogen bonds than peptidic protease inhibitors, which results in increased flexibility, allowing it to fit into the active site of the enzyme in viruses that have become resistance to other protease inhibitors. This also enables tipranavir to adjust to amino acid substitutions at the active site. 2. Tipranavirs strong hydrogen bonding interaction with the amide backbone of the protease active site Asp30 may lead to its activity against resistant viruses.
N-[3-[(1S)-1-[(6R)-2,4-Dioxo-6-(2-phenylethyl)-6-propyloxan-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
Epipodophyllotoxin derivitive
QUINOLONE DERIVATIVE
(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)
2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-
(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside
lissoclibadin 2
C26H38N2O4S5 (602.1435028000001)
An organosulfur heterocyclic compound isolated from the ascidian Lissoclinum badium. It has been shown to exhibit cytotoxicity against human cancer cell lines.
3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D
(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside
(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose
1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose
1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose
1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid
Picrotoxin
C15H18O7. C15H16O6 (602.1999314)
Cocculus appears as a poisonous berry, the dried fruit of Anamirta cocculus L. Contains several substances including about one percent picrotoxin. Pure picrotoxin occurs as shiny leaflets with an intensely bitter taste or as a microcrystalline powder. Very poisonous!. Used in medicine as a central nervous system stimulant and antidote for barbiturate poisoning. Not currently regarded as a useful therapeutic agent. A mixture of PICROTOXININ and PICROTIN that is a noncompetitive antagonist at GABA-A receptors acting as a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D020011 - Protective Agents > D000931 - Antidotes
[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate
Tipranavir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
Eriodictyol 7-(6-galloylglucoside)
2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide
C34H35BrO5 (602.1667719999999)
4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione
2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)
2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide
C34H35BrO5 (602.1667719999999)
AVE 0991 sodium salt
C29H31N4NaO5S2 (602.1633476000001)
AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM[1].
14c-Tipranavir
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid
C31H25F2N4O3PS (602.1352973999999)
(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside
A monosaccharide derivative that is eriodictyol attached to a (6-O-galloyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.
7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl 6-(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1,6-dicarboxylate
C28H30N2O13 (602.1747809999999)
(13r,23r)-13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
4-[(2-carboxyacetyl)oxy]-3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
6'-o-p-hydroxybenzoylcatalposide
{"Ingredient_id": "HBIN012712","Ingredient_name": "6'-o-p-hydroxybenzoylcatalposide","Alias": "NA","Ingredient_formula": "C29H30O14","Ingredient_Smile": "C1=COC(C2C1C(C3C2(O3)CO)OC(=O)C4=CC=C(C=C4)O)OC5C(C(C(C(O5)COC(=O)C6=CC=C(C=C6)O)O)O)O","Ingredient_weight": "602.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706008","DrugBank_id": "NA"}
(6r,7r,8r)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid
(1s,3r,4s,5r)-4-[(2-carboxyacetyl)oxy]-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate
(6r,7s,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
(6s,7s,8s)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate
(1s,3r,4s,5r)-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid
(6'r,7'r,8'r)-2,4',6',7',8,8'-hexahydroxy-2',6-dimethoxy-3,7'-dimethyl-6',8'-dihydro-5'h-[1,1'-bianthracene]-9,9',10,10'-tetrone
4-[(2s,5r)-9'-[(3,3-dimethyloxiran-2-yl)methoxy]-4'-methoxy-4,4-dimethylspiro[1,3-dioxolane-2,7'-furo[3,2-g]chromen]-5-ylmethoxy]furo[3,2-g]chromen-7-one
1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
(13s,23r)-13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
8-{9,10-dihydroxy-5,7-dimethoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-9,10-dihydroxy-5,7-dimethoxy-3-methylbenzo[g]isochromen-1-one
[(2r,3s,4s,5r,6s)-6-{[(2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(2s,3r)-1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate
4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)
1-[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl] 6-(3,4,5-trihydroxy-6-methyloxan-2-yl) phenazine-1,6-dicarboxylate
C28H30N2O13 (602.1747809999999)
(2-{15-[2-(dimethylamino)ethyl]-6,7,12,13-tetramethoxy-5,14-bis(methylsulfanyl)-2,9,10-trithiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-4-yl}ethyl)dimethylamine
C26H38N2O4S5 (602.1435028000001)